NCT02112513View on ClinicalTrials.gov

The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 8, 2016

Study Completion Date

June 30, 2017

Conditions
Neonatal Respiratory Distress Syndrome
Trial Locations (2)

46202

Eskenazi Hospital, Indianapolis

Methodist Hospital, Indianapolis

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Indiana University

OTHER

NCT02112513 - The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter